Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
Transplantation and Cellular Therapy|December 1, 2021
Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in ChildrenFederica Forlanini, Matt S Zinter, Christopher C Dvorak, et al.
Pediatric Blood & Cancer|March 7, 2022
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patientsChristine S Higham, Kristin A Shimano, Alexis Melton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell TransplantsCristina F Contreras, Janel R Long-Boyle, Kristin A Shimano, et al.
Blood Advances|April 20, 2021
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxisChristine S Higham, Griffin Collins, Kristin A Shimano, et al.
Pediatric Blood & Cancer|March 25, 2021
Quality of life is an important indication for second-line treatment in children with immune thrombocytopeniaKristin A Shimano, Cindy Neunert, James B Bussel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2019
Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined ImmunodeficiencyChristopher C Dvorak, Janel Long-Boyle, Jasmeen Dara, et al.
Transplantation and Cellular Therapy|June 29, 2024
Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic MicroangiopathyChristine S Higham, Kristin A Shimano, Sandhya Kharbanda, et al.
Blood Vessels, Thrombosis & Hemostasis|February 2, 2026
Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypesDeeti J Pithadia, Marina J Heskel, Arman Shotayev, et al.
Transplantation and Cellular Therapy|April 17, 2024
Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric ProtocolsGabriel Salinas Cisneros, Christopher C Dvorak, Janel Long-Boyle, et al.
Pageof 4